Polycystic Ovary Syndrome (PCOS)

References

Citations

1. Barbieri RL (2007). Polycystic ovary syndrome. In DC Dale, DD Federman, eds., ACP Medicine, section 16, chap. 5. New York: WebMD.

2. Ehrmann DA (2005). Polycystic ovary syndrome. New England Journal of Medicine, 352(12): 1223–1236.

3. Speroff L, Fritz MA (2005). Anovulation and the polycystic ovary. Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 465–498. Lippincott Williams and Wilkins.

4. Huang I, et al. (2007). Endocrine disorders. In JS Berek, ed., Berek and Novak's Gynecology, 14th ed., pp. 1069–1135. Philadelphia: Lippincott Williams and Wilkins.

5. Elsenbruch S, et al. (2003). Quality of life, psychological well-being, and sexual satisfaction in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(12): 5801–5807.

6. American Association of Clinical Endocrinologists (2005). Position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome. Endocrine Practice: 11(2): 126–134.

7. Speroff L, Fritz MA (2005). Recurrent early pregnancy loss. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 1069–1101. Philadelphia: Lippincott Williams and Wilkins.

8. Haas DA, et al. (2003). Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertility and Sterility, 79(3): 469–481.

9. American College of Obstetricians and Gynecologists (2002, reaffirmed 2008). Management of infertility caused by ovulatory dysfunction. ACOG Practice Bulletin No. 34. Obstetrics and Gynecology, 99(2): 347–358.

10. Stegmann BJ, et al. (2003). Characteristics predictive of response to ovarian diathermy in women with polycystic ovarian syndrome. American Journal of Obstetrics and Gynecology, 188(5): 1171–1173.

Other Works Consulted

• Cahill D (2009). PCOS, search date December 2007. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

• American College of Obstetricians and Gynecologists (2009). Polycystic ovary syndrome. ACOG Practice Bulletin No. 108. Obstetrics and Gynecology, 114(4): 936–949.

• Dronavalli S, Ehrmann DA (2007). Pharmacologic therapy of polycystic ovary syndrome. Clinical Obstetrics and Gynecology, 50(1): 244–254.

• Hall J (2007). Neuroendocrine changes with reproductive aging in women. Seminars in Reproductive Medicine, 25(5): 344–351.

• Polycystic Ovary Syndrome Writing Committee (2005). American Association of Clinical Endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome. Endocrine Practice, 11(2): 125–134.

• Practice Committee of the American Society for Reproductive Medicine (2006). The evaluation and treatment of androgen excess. Fertility and Sterility, 86(4, Suppl): S241–S247.

• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2003). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1): 19–25.

• Setji T, Brown AJ (2007). Polycystic ovary syndrome: Diagnosis and treatment. American Journal of Medicine, 120(2): 128–132.

• Thatcher SS, Jackson EM (2006). Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertility and Sterility, 85(4): 1002–1009.

Go to previous section	Go to top of page	Go to next section
Author:	Sandy Jocoy, RN	Last Updated: January 23, 2010
Medical Review:	Sarah Anne Marshall, MD - Family Medicine Kirtly Jones, MD - Obstetrics and Gynecology
© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.